ProShare Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $240K | Buy |
|
|||||
|
2023
Q4 | $225K | Buy |
|
|||||
|
2023
Q3 | $152K | Buy |
|
|||||
|
2023
Q2 | $167K | Buy |
|
|||||
|
2023
Q1 | $175K | Sell |
|
|||||
|
2022
Q4 | $189K | Buy |
|
|||||
|
2022
Q3 | $196K | Buy |
|
|||||
|
2022
Q2 | $135K | Sell |
|
|||||
|
2022
Q1 | $125K | Sell |
|
|||||
|
2021
Q4 | $164K | Sell |
|
|||||
|
2021
Q3 | $593K | Sell |
|
|||||
|
2021
Q2 | $755K | Buy |
|
|||||
|
2021
Q1 | $820K | Buy |
|
|||||
|
2020
Q4 | $984K | Buy |
|
|||||
|
2020
Q3 | $701K | Sell |
|
|||||
|
2020
Q2 | $837K | Buy |
|
|||||
|
2020
Q1 | $340K | Sell |
|
|||||
|
2019
Q4 | $853K | Sell |
|
|||||
|
2019
Q3 | $524K | Buy |
|
|||||
|
2019
Q2 | $272K | Sell |
|
|||||
|
2019
Q1 | $319K | Buy |
|
|||||
|
2018
Q4 | $287K | Buy |
|